Literature DB >> 931207

Iron balance in hemodialysis patients.

J W Eschbach, J D Cook, B H Scribner, C A Finch.   

Abstract

Iron deficiency is a frequent complication in chronically hemodialyzed patients because of the significant blood losses associated with this technique. Quantitating iron stores (by marrow examination or serum iron and total iron-binding capacity) on a repetitive basis had been difficult or unreliable, often resulting in failure to recognize iron deficiency superimposed on the existing anemia of chronic renal failure, or overtreating, which can lead to iron excess. Use of the serum ferritin allows easier quantitation of iron stores and, when measured serially in dialysis patients, can predict the emergence of iron deficiency. There was no correlation between serum ferritin levels and serum iron, total iron-binding capacity, or percent transferrin saturation. Iron absorption studies show that food iron absorption is physiologic, increasing when the serum ferritin is below 30 ng/ml, decreasing when more than 300 ng/ml. Treatment of iron deficiency with oral iron compounds increases serum ferritin levels and usually can maintain iron balance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 931207     DOI: 10.7326/0003-4819-87-6-710

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

1.  Mean Corpuscular Volume and Mortality in Patients with CKD.

Authors:  Yao-Peng Hsieh; Chia-Chu Chang; Chew-Teng Kor; Yu Yang; Yao-Ko Wen; Ping-Fang Chiu
Journal:  Clin J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 8.237

Review 2.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

3.  Hepatic hemosiderosis in maintenance hemodialysis (MHD) patients.

Authors:  T Kothari; A P Swamy; J C Lee; J C Mangla; R V Cestero
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

Review 4.  Erythropoiesis and erythropoietin levels in renal transplant recipients.

Authors:  M Wolff; W Jelkmann
Journal:  Klin Wochenschr       Date:  1991-01-22

Review 5.  Iron supplementation to treat anemia in patients with chronic kidney disease.

Authors:  Anatole Besarab; Daniel W Coyne
Journal:  Nat Rev Nephrol       Date:  2010-10-19       Impact factor: 28.314

6.  A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.

Authors:  Chia Chi Sun; Valentina Vaja; Shanzhuo Chen; Igor Theurl; Aaron Stepanek; Diane E Brown; Maria D Cappellini; Guenter Weiss; Charles C Hong; Herbert Y Lin; Jodie L Babitt
Journal:  Nephrol Dial Transplant       Date:  2013-01-22       Impact factor: 5.992

Review 7.  Past, present and future of erythropoietin use in the elderly.

Authors:  Angel L M de Francisco; Gema Fernandez Fresnedo; Emilio Rodrigo; Celestino Piñera; Milagros Heras; Rosa Palomar; Juan C Ruiz; Manuel Arias
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 8.  Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?

Authors:  Takeshi Nakanishi; Takahiro Kuragano; Shoji Kaibe; Yasuyuki Nagasawa; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2012-09-29       Impact factor: 2.801

9.  Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Authors:  Karthik K Tennankore; Steven D Soroka; Kenneth A West; Bryce A Kiberd
Journal:  BMC Nephrol       Date:  2011-05-11       Impact factor: 2.388

10.  Ferrokinetics in patients on CAPD: influence of CAPD on the anemia of uremia.

Authors:  H B Lee; S W Koh; H S Park
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.